Rench Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-33,787
Closed -$2.28M 49
2019
Q2
$2.28M Buy
33,787
+955
+3% +$62.8K 1.46% 35
2019
Q1
$2.13M Sell
32,832
-1,696
-5% -$113K 1.4% 36
2018
Q4
$2.16M Buy
34,528
+2,281
+7% +$159K 1.58% 32
2018
Q3
$2.49M Buy
32,247
+1,144
+4% +$86.4K 1.66% 32
2018
Q2
$2.2M Sell
31,103
-310
-1% -$21.9K 1.59% 36
2018
Q1
$2.37M Sell
31,413
-816
-3% -$64.9K 1.62% 33
2017
Q4
$2.31M Buy
32,229
+1,973
+7% +$150K 1.5% 36
2017
Q3
$2.45M Buy
30,256
+2,403
+9% +$184K 1.69% 31
2017
Q2
$1.97M Buy
27,853
+212
+0.8% +$14.1K 1.46% 35
2017
Q1
$1.88M Buy
27,641
+1,717
+7% +$121K 1.39% 36
2016
Q4
$1.86M Buy
25,924
+1,168
+5% +$86.8K 1.47% 34
2016
Q3
$1.96M Buy
24,756
+20,967
+553% +$1.7M 1.58% 33
2016
Q2
$316K Sell
3,789
-5
-0.1% -$444 0.26% 36
2016
Q1
$348K Sell
3,794
-1,643
-30% -$148K 0.29% 35
2015
Q4
$550K Buy
5,437
+1,572
+41% +$164K 0.47% 31
2015
Q3
$380K Sell
3,865
-2,319
-38% -$258K 0.35% 34
2015
Q2
$724K Buy
6,184
+1,943
+46% +$212K 0.63% 32
2015
Q1
$416K Buy
4,241
+1,318
+45% +$134K 0.36% 33
2014
Q4
$276K Buy
+2,923
New +$302K 0.23% 37

Other funds holding GILD

Rench Wealth Management's GILD Position: Q3 2019 in Review

Rench Wealth Management sold out of Gilead Sciences (GILD) in Q3 2019, closing a stake of 33,787 shares — an estimated $2.28M sold.

Rench Wealth Management first reported a position in GILD in Q4 2014 and held it in 19 quarters. The position peaked at $2.49M in Q3 2018. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.

  • Rench Wealth Management reported no remaining Gilead Sciences position as of Q3 2019 after selling out during the quarter.
  • Rench Wealth Management sold 33,787 Gilead Sciences shares in Q3 2019, an estimated $2.28M.
  • Rench Wealth Management first reported a position in Gilead Sciences in Q4 2014 and held it in 19 quarters.
  • Rench Wealth Management's Gilead Sciences position peaked at $2.49M in Q3 2018.
  • 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.

Based on Rench Wealth Management's 13F filing for Q3 2019, filed 14 Nov 2019.